Disease Diagnosis TRIZ Cases

Metabolite biomarker analysis stratifies Alzheimer's disease subjects by sex and APOE genotype status.

Reagents detect human autoantibodies against specific proteins in bodily fluids to monitor breast cancer therapy efficacy.

A blood analyzer generates support information by integrating analysis data from multiple blood cell types to enhance diagnostic precision.

Measuring MIC-1 serum levels predicts prostate cancer progression and survival, replacing invasive biopsies to reduce unnecessary aggressive treatments.

Antibodies bind surrogate light chains to enable precise biomarker detection in clinical diagnostics.

Fluorescent microspheres conjugated with specific peptides detect anti-Zika antibodies via multiplex immunoassay.

Activated macrophages absorb brain marker proteins to enable peripheral detection of neurodegenerative conditions.

Fluorescent probes bind unbound bilirubin to measure toxic levels, resolving the contradiction between total bilirubin accuracy and neurotoxicity assessment.

Monoclonal antibody isolates citrullinated autoantigens to eliminate false positives from non-specific autoantibodies in rheumatoid arthritis testing.

Modular nanoparticles release detectable markers upon protease cleavage for affinity-based capture assays.

An inert reference antibody corrects therapeutic antibody concentrations in brain tissue samples by accounting for residual blood interference.

Mass spectrometry identifies kappa and lambda free light chains by mass-to-charge ratio, resolving monoclonal gammopathies from polyclonal backgrounds.

Mass spectroscopy analysis of culture media proteins selects viable embryos, reducing multiple pregnancy risks.

Segmented ELISA assays differentiate nitrated from total hemopexin to resolve measurement precision limits in sepsis diagnosis.

Segmented capture reagents detect low-abundance proteins to resolve sensitivity and complexity trade-offs in near-term prediction.

Antibody-mediated detection of Na/K-ATPase Y260 phosphorylation resolves measurement precision challenges to diagnose cancer via Src signaling assessment.

Segmented test zones within a capillary tube enable rapid pathogen detection, eliminating extended incubation times required by conventional planar assays.

Trained animal bio-sensors detect volatile organic compounds in breath samples, replacing invasive radiation procedures and reducing false positives.

An immunochromatography strip detects PBP2′ protein using labeled antibodies and capture reagents.

Measuring cMet-positive T cells enables early detection of cardiac inflammation before symptoms appear, resolving the timing bottleneck.

Analyzing perfusate fluid proteins during hypothermic perfusion to predict organ suitability and reduce ischemic reperfusion injury.

Boiling serum samples denatures interfering proteins before antibody binding, eliminating false positives and negatives in Aspergillus diagnosis.